Sitemap


Medigene AG -Search
Company
Company Profil
Business Strategy
Management
Contact
Imprint
Products & Pipeline
Products and clinical projects
Drugs on the market:
Eligard ®
Veregen ®
Projects in clinical development:
EndoTAG TM-1
RhuDex ®
Oncolytic viruses (HSV)
Technologies:
EndoTAG TM
AAVLP
Oncolytic viruses (HSV)
Strategic Investments
Immunocore Ltd.
Catherex, Inc.
Targeted Indication
News
News
Press Releases
Medigene AG -
Ad hoc Press Releases
Conferences and Events
Webcast
Medigene AG - Press Releases
Investor Relations
Investor Relations Contact
The MediGene Stock
Börsenkurs
Quotes & Charts
Kapitalmaßnahmen
Capital measures
Aktienkennung
Medigene AG -
Financial Calendar
Conference Calendar
Reports
General Meeting
Archive
2009
2010
News
Analysts Coverage
Corporate Governance
Medigene AG - Corporate Governance
Medigene AG - Corporate Governance
Medigene AG - Corporate Governance
Medigene AG - Corporate Governance
Medigene AG - Corporate Governance
Medigene AG - Corporate Governance
Medigene AG - Corporate Governance
Medigene AG -
Medigene AG - Corporate Governance
Company Presentation
Career Opportunities
Career Opportunities
Our guiding principles
Our guiding principles
Job Vacancies
Job Vacancies
Partnering & Licensing
Partnering & Licensing